Is OPK Fibbin'?OPK back at the .236 fib line, which has been a clear area of support/resistance. The question is, will the speculation on its testing company end up giving the boost needed to push back above the $5 mark or is this truly a "fib" and OPK falls back down heading into the rest of March?
"Ongoing pressure from an activist investor to offload its BioReference unit has also become a source of speculation. This stemmed from recent M&A action within the diagnostics space earlier this month. Needless to say, the recent action in the stock has continued supporting some analysts’ bullish stances on the company. Most recently, Barrington Research boosted its price target to $8 from $7 and maintained its Outperform rating."
Quote Source: Best Penny Stocks On Robinhood To Watch This Week If You Like Biotech
OPK
OPK (Opko Health Inc.)OPK is the official covid test of the NFL, which was announced mid/early July. I think now some of that FOMO has been shaken out off that news. Whether or not there is a wave 2 (don't science at me please) people will continue to be tested, and often if playing pro sports. If OPK has a legit test (the NFL thinks so) then this could be around for a while. Areas of resistance I am watching are diagonal black line and horizontal green lines (monthly areas of interest). I am long and plan on holding this until the virus outlook is sunshine and roses. Cheers!
Finally some bullish momentum for $OPK ?Keeping an eye on $OPK.
The shares price just crossed previous 2.90$ which was both resistance and 52 weeks high.
If the price remain above previous resistance and become the new support, we could see the price spike up!
Long term still not sure, but there is bullish momentum on this stock IMO
Reason for jumpShares of OPKO Health (NASDAQ:OPK) were soaring 23% at 11:15 a.m. EDT on Tuesday after management disclosed on Monday it will provide coronavirus testing to all 32 teams in the National Football League.
OPKO Health's wholly owned subsidiary, BioReference Labs is the nation's third-largest diagnostics laboratory.
Fastest test result turnaround in the industry has landed the company impressive state, local, and sports contracts.
$OPK updated chart potential bullish setup$OPK has been on a roll lately with recent news with their 4 month subsidy from the CDC and the Cramer Mad Money interview stating contracts with NFL for regular testing and a potential comeback of the season.
With almost 30% short interest I think this is bound for a short squeeze soon unless some sort of news suddenly makes it drop.
Consider entries on pullbacks and taking profits where the stars are located on the chart/fib levels.
ALWAYS TAKE PROFIT!!!! Who knows if a big institution could suddenly dump this stock! Take partial profits if you plan on going all the way!
Keep in mind I am not a financial advisor and this information is strictly for educational purposes only.
$OPK Potential Long Breakout SetupOPKO Health is a medical testing company based on diagnostics and pharmaceuticals. They also have a COVOID-19 testing kit.
During week of June 6th, Insider buying occurred with CEO, Chairman and 10% Owner Phillip Frost buying 200,000 shares at the average price of $2.35.
With COVOID-19 infections slowly ticking up in the US, we might see more demand in the company's testing kits.
$OPK recently retook the 100 day MA on the weekly chart which hasn't been crossed since 2017 which could mark a strong trend coming soon.
$OPK is also looking at a breakout past the hourly resistance at $2.91 and also a potential gap fill at $3.00 to a target of $3.30
Also high short interest at 29%
Keep in mind I am not a financial advisor and this information is strictly for educational purposes only.
$COCP Short Articles Published Drowned out by FACTS PPS Rises03-06-2020, 3.5 Million Share Institutional Buy-In tells only a snippet of the overall story with this dream stock.
sec.report
To get the real grasp of what we have here, look to my previous post and take in this analogy as deeply as possible:
In the Coronavirus Market: $COCP is to Treatment what $IBIO is to Vaccines or what $OPK is to Testing.
$COCP has completed all the financing and funding needed with two public offerings recently and are now aggressively pursing the development of Novel Anitiviral Compounds for treatment of any Corona infections including COVID-19
They have exclusive patent rights to the treatment and are in the process of advancing it quickly through a preclinical trial program.
Shorts will continue to write articles to downplay these facts as much as possible because the stock has a HUGE short position